Quince therapeutics appoints dr. charles s. ryan as president

South san francisco, calif.--(business wire)---- $qncx--quince therapeutics, inc. (nasdaq: qncx), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients' lives, today announced the appointment of charles s. ryan, j.d., ph.d. as president. in this new position, dr. ryan will be responsible for the company's corporate legal activities and intellectual property portfolio, and pending the completion of its planned acquisition of erydel s.
QNCX Ratings Summary
QNCX Quant Ranking